CITY OF INDUSTRY, Calif., Jan. 21, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTC BB:UBDF.OB - News) announced today that it is developing an Open Source Stem Cell Research Platform to leverage the distributed power of open source development. The Open Source Stem Cell Research Platform will allow researchers at universities, government agencies, and Fortune 500 companies to read, distribute, modify and contribute to stem cell and biotechnology research in an efficient and streamlined method. The platform, which can be used as an Intranet or online, will provide access to bioinformatic tools and serve as a robust utility for the rapid evolution of Stem Cell technology research, development, and commercialization.
